Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 3 | 2018 | 167 | 1.520 |
Why?
|
| Neoplasms | 3 | 2022 | 54 | 1.360 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 61 | 1.140 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 5 | 0.670 |
Why?
|
| Curcumin | 1 | 2018 | 7 | 0.670 |
Why?
|
| Glucose | 1 | 2018 | 39 | 0.670 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 45 | 0.670 |
Why?
|
| Metabolic Syndrome | 1 | 2017 | 23 | 0.610 |
Why?
|
| Smad4 Protein | 1 | 2017 | 2 | 0.610 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 3 | 0.610 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 22 | 0.610 |
Why?
|
| Inflammation | 1 | 2017 | 44 | 0.610 |
Why?
|
| Lactic Acid | 1 | 2016 | 4 | 0.600 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 25 | 0.590 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 32 | 0.590 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 81 | 0.570 |
Why?
|
| Humans | 8 | 2022 | 2493 | 0.550 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 114 | 0.540 |
Why?
|
| Glycolysis | 1 | 2015 | 4 | 0.540 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 12 | 0.540 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 31 | 0.530 |
Why?
|
| Animals | 5 | 2022 | 1238 | 0.520 |
Why?
|
| Phosphorylation | 4 | 2018 | 68 | 0.490 |
Why?
|
| Cell Line, Tumor | 4 | 2018 | 138 | 0.470 |
Why?
|
| Female | 4 | 2018 | 1733 | 0.420 |
Why?
|
| NF-kappa B | 2 | 2018 | 26 | 0.320 |
Why?
|
| Disease Progression | 2 | 2018 | 50 | 0.320 |
Why?
|
| Signal Transduction | 3 | 2017 | 180 | 0.310 |
Why?
|
| STAT1 Transcription Factor | 2 | 2017 | 6 | 0.310 |
Why?
|
| Telomerase | 2 | 2017 | 8 | 0.310 |
Why?
|
| Cell Proliferation | 3 | 2017 | 110 | 0.300 |
Why?
|
| STAT3 Transcription Factor | 2 | 2017 | 21 | 0.300 |
Why?
|
| Colorectal Neoplasms | 2 | 2017 | 21 | 0.300 |
Why?
|
| Mice | 2 | 2018 | 508 | 0.280 |
Why?
|
| Apoptosis | 2 | 2017 | 162 | 0.270 |
Why?
|
| Exosomes | 1 | 2022 | 6 | 0.210 |
Why?
|
| Interleukin-6 | 2 | 2017 | 21 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 26 | 0.190 |
Why?
|
| Models, Molecular | 1 | 2018 | 3 | 0.170 |
Why?
|
| Acetylation | 1 | 2018 | 7 | 0.170 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2018 | 7 | 0.170 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 11 | 0.170 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 36 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2018 | 20 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 25 | 0.170 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 143 | 0.160 |
Why?
|
| Withanolides | 1 | 2017 | 3 | 0.160 |
Why?
|
| Ubiquitination | 1 | 2017 | 3 | 0.150 |
Why?
|
| Pyrans | 1 | 2017 | 4 | 0.150 |
Why?
|
| Hyperinsulinism | 1 | 2016 | 6 | 0.150 |
Why?
|
| Cell Movement | 1 | 2017 | 29 | 0.150 |
Why?
|
| Mice, Nude | 1 | 2017 | 36 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 19 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 67 | 0.150 |
Why?
|
| Phenotype | 1 | 2016 | 40 | 0.150 |
Why?
|
| Diabetes Complications | 1 | 2016 | 24 | 0.150 |
Why?
|
| Insulin Resistance | 1 | 2016 | 44 | 0.150 |
Why?
|
| Organelle Biogenesis | 1 | 2015 | 2 | 0.140 |
Why?
|
| Obesity | 1 | 2017 | 102 | 0.140 |
Why?
|
| Intracellular Space | 1 | 2015 | 3 | 0.140 |
Why?
|
| Deoxyglucose | 1 | 2015 | 6 | 0.140 |
Why?
|
| Cell Survival | 1 | 2015 | 17 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 12 | 0.140 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 17 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 13 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2015 | 22 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 12 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 35 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 118 | 0.130 |
Why?
|
| Male | 1 | 2017 | 1649 | 0.110 |
Why?
|
| HT29 Cells | 2 | 2017 | 9 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2017 | 14 | 0.080 |
Why?
|
| Ligands | 1 | 2022 | 15 | 0.050 |
Why?
|
| Models, Biological | 1 | 2022 | 43 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2022 | 41 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 9 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2017 | 116 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 14 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 35 | 0.040 |
Why?
|
| beta Catenin | 1 | 2017 | 16 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 28 | 0.040 |
Why?
|
| Benzamides | 1 | 2017 | 13 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 24 | 0.040 |
Why?
|